Boosted by its exclusive agreement with Regeneron, Kiniksa Pharmaceuticals stands among the top biotech stocks to watch.

Biotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late-stage and commercial assets.

I can sit through a biotech presentation and come away convinced that the company has discovered the answer to half the ...

Alaunos Therapeutics (NASDAQ: TCRT) jumps over 146% after completing its Velaris Therapeutics acquisition and a concurrent ...

Three biotech stocks are making their mark, hovering around the top of the IBD 50 list, and even held all three top slots at one time over the past week. Eight biotech stocks made the list but Travere ...

Affinity Technologies (Nasdaq: BIAF) soars after the Japan Patent Office issues a Notice of Allowance for its CyPath Lung ...

All that has changed, and if you want to invest in growth away from AI, biotech might be where you want to be. Below, I will attempt to lay out the various macro and policy disruptions that had a ...

Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply higher. A small group of biotechs is building real commercial businesses ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...